Feedback plc (LON:FDBK – Get Free Report)’s share price traded down 15.4% on Thursday. The stock traded as low as GBX 5.50 and last traded at GBX 5.50. Approximately 277,038 shares changed hands during mid-day trading, an increase of 140% from the average daily volume of 115,333 shares. The stock had previously closed at GBX 6.50.
Feedback Stock Performance
The stock has a 50 day moving average of GBX 6.58 and a two-hundred day moving average of GBX 8.96. The stock has a market cap of £2.41 million, a PE ratio of -0.35 and a beta of 0.77.
Feedback Company Profile
Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.
Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.
By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.
Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.
See Also
- Five stocks we like better than Feedback
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
- Constellation Energy’s Nuclear Expansion Gets a $5 Billion Opening, Not a Guarantee
- Plugging In: Vertiv Cashes In On AI Demand
Receive News & Ratings for Feedback Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Feedback and related companies with MarketBeat.com's FREE daily email newsletter.
